Business Context and Reporting Period
Company: Inmune Bio, Inc. (INMB)
Filing Type: Form 8-K (Current Report)
Date of Report: October 24, 2024
Reporting Period Context: This filing announces an upcoming conference call to discuss financial results for the quarter ended September 30, 2024.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a notification of an upcoming event and does not contain the financial data itself.
Material Changes
No material changes to financial performance or operations are detailed in this filing. The document references a press release (Exhibit 99.1) for further details but does not include the content of that release.
Guidance, Outlook, and Management Commentary
- Upcoming Event: The Company will host a conference call on Thursday, October 31, 2024, at 4:30 pm EDT.
- Call Agenda: Discussion of results for the quarter ended September 30, 2024, and a corporate update.
- Emerging Growth Company Status: The registrant is identified as an emerging growth company.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for specific financial figures.
- Confirm the date and time of the conference call (October 31, 2024, 4:30 pm EDT) to access management commentary.
- Review the upcoming quarterly report (10-Q) for the period ended September 30, 2024, once filed for audited financial data.